A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT

Completed

Conditions studied: Autistic Disorder

In brief

The purpose of this study is to continue to evaluate the long-term effectiveness of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in children with Autism Spectrum Disorder (ASD). No active MeRT treatment will be performed in this study.

Key facts

Study ID

NCT02746445

Run by

Wave Neuroscience

People needed

11

Starts

2016-04-01

Expected to finish

2017-04-01

Last updated by the study team

2017-05-09

Who can join

Age: 6 and older, up to 15. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must have completed the MeRT-001 (formerly known as MRT-001) clinical trial conducted by the Brain Treatment Center (BTC)
• Age between 6 and 15 years (at day of informed consent)
• Willing and able to adhere to the study visits

You may not qualify if…

• Subjects who did not participate in the MeRT-001 clinical trial.
• Any condition which in the judgment of the investigator would prevent the subject from completion of the study.

Where it is running

• Brain Treatment Center — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.